Physician profile
Dave Yu Chua
NPI 1508807280
$1,830.14
in general payments reported to CMS, 2019-2025
16 companies · $378 in 2025
The $378 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $11.72 · 2021: $190 · 2022: $256 · 2023: $300 · 2024: $308 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $366.54 | 2021-2025 | Cardiomems |
| Pfizer INC. | $276.25 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $189.36 | 2019-2024 | Farxiga |
| Edwards Lifesciences Corporation | $177.42 | 2024-2025 | Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $175.98 | 2019-2021 | |
| Ancora Heart, INC. | $166.43 | 2024 | Accucinch |
| Actelion Pharmaceuticals US, INC. | $116.78 | 2025 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $81.15 | 2022 | |
| Kestra Medical Technology Services, INC. | $79.60 | 2024 | Assure Wcd |
| Heartflow, INC. | $70.62 | 2025 | |
| Akcea Therapeutics, INC. | $52.33 | 2019 | |
| Lantheus Medical Imaging, INC. | $20.69 | 2023 | Definity |
| Tactile Systems Technology INC | $20.04 | 2019 | |
| Echosens North America, INC. | $13.40 | 2025 | Fibroscan |
| Boston Scientific Corporation | $11.83 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dave Chua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.